Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients.

Kessler Iglesias C, Bloom JE, Xiao X, Moskovitch J, Eckford H, Offen S, Kotlyar E, Keogh A, Jabbour A, Bergin P, Leet A, Hare JL, Taylor AJ, Hayward CS, Jansz P, Kaye DM, Macdonald PS, Muthiah K. Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients. Transplantation. 2025 02 01; 109(2):346-351.

View in: PubMed

subject areas

Adult
Aspirin
Coronary Angiography
Coronary Artery Disease
Female
Graft Rejection
Heart Transplantation
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome

authors with profiles

Andrew Taylor, Ph.D.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support